Sean Morris is a highly experienced Executive-level professional with experience in managing the functions of sales, marketing, strategy and R&D in both public and private company environments.
He has significant experience in market assessment, global product development, business development and commercialization.
Sean was the Founder of Veniti, a venous stent company that was acquired by Boston Scientific in 2018. Sean is currently founder and CEO of Euphrates Medical, an early stage, venture backed, medical device start-up pioneering a nano-scale endovascular therapeutic technology for stroke and peripheral vascular disease.
He has significant fundraising experience with traditional vehicles; Seed, Venture, Strategic Financing and Debt, having raised in excess of $80M. Prior to Veniti, Sean was Senior Vice President and General Manager, Peripheral Vascular Division, Angiodynamics Inc.